PolyPeptide Group AG (0AAJ) Share Forecast & Price Target
0AAJ Analyst Ratings
Hold
0Buy3Hold0Sell
Based on 3 analysts giving stock ratings to PolyPeptide Group AG in the past 3 months
0AAJ Stock 12 Month Forecast
Average Price Target
CHF 44.10â–˛(4.51% Upside)Based on 3 Wall Street analysts offering 12 month price targets for PolyPeptide Group AG in the last 3 months. The average price target is CHF 44.10 with a high forecast of CHF 44.31 and a low forecast of CHF 44.00. The average price target represents a 4.51% change from the last price of CHF 42.20.
Past 12 Months12 Month ForecastDec2025Sep2026
HighCHF 44.31
AverageCHF 44.10
LowCHF 44.00
Highest Price TargetHighestCHF 44.31Average Price TargetCHF 44.10Lowest Price TargetLowestCHF 44.00
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Tanya Hansalik | UBS | CHF 45→CHF 44 | hold | 4.27%Upside | Downgraded | 10/06/26 | ||
| Charles Pitman CFA | Barclays | CHF 44.31 | hold | 5.00%Upside | Reiterated | 09/08/26 | ||
| Estelle Betrisey | Berenberg Bank | CHF 38→CHF 44 | hold | 4.27%Upside | Downgraded | 08/18/26 | ||
| Charles Weston | RBC Capital | CHF 44 | hold | 4.27%Upside | Downgraded | 07/07/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Tanya Hansalik | 10/06/26 | CHF 45→CHF 44 | hold | 4.27%Upside | Downgraded | UBS | ||
| Charles Pitman CFA | 09/08/26 | CHF 44.31 | hold | 5.00%Upside | Reiterated | Barclays | ||
| Estelle Betrisey | 08/18/26 | CHF 38→CHF 44 | hold | 4.27%Upside | Downgraded | Berenberg Bank | ||
| Charles Weston | 07/07/26 | CHF 44 | hold | 4.27%Upside | Downgraded | RBC Capital |
Stocks with the Highest Top Analyst Consensus in the General Sector
0AAJ Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 4 | 3 | 0 | 0 |
| Hold | 0 | 1 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 7 | 5 | 6 | 4 | 4 |
In the current month, 0AAJ has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. 0AAJ average Analyst price target in the past 3 months is 44.10.
0AAJ Financial Forecast
HighCHF 0.36
ConsensusCHF 0.36
LowCHF 0.36
0AAJ Earnings Forecast
Next quarter’s earnings estimate for 0AAJ is CHF 0.36 with a range of CHF 0.36 to CHF 0.36. The previous quarter’s EPS was CHF 0.26. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighCHF 237M
ConsensusCHF 237M
LowCHF 237M
0AAJ Sales Forecast
Next quarter’s sales forecast for 0AAJ is CHF 236.76M with a range of CHF 236.76M to CHF 236.76M. The previous quarter’s sales results were CHF 217.20M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
0AAJ Stock Forecast FAQ
What is GB:0AAJ’s average 12-month price target, according to analysts?
Based on analyst ratings, PolyPeptide Group AG’s 12-month average price target is CHF44.10.
What is GB:0AAJ’s upside potential, based on the analysts’ average price target?
PolyPeptide Group AG has 4.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PolyPeptide Group AG a Buy, Sell or Hold?
PolyPeptide Group AG has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is PolyPeptide Group AG’s share price target?
The average share price target for PolyPeptide Group AG is CHF44.10. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF44.31, and the lowest forecast is CHF44.00. The average share price target represents a 4.51% increase from the current price of CHF42.2.
What do analysts say about PolyPeptide Group AG?
PolyPeptide Group AG’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of PolyPeptide Group AG?
To buy shares of GB:0AAJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
